Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Acta Physiologica Sinica ; (6): 718-722, 2014.
Article in Chinese | WPRIM | ID: wpr-255982

ABSTRACT

This study is aimed to investigate the effects of high intracellular Mg²⁺ on L-type calcium channel in guinea-pig ventricular myocytes. The cardiomyocytes were acutely isolated with enzyme digestion method. By adopting inside-out configuration of patch clamp technique, single channel currents of the L-type calcium channel were recorded under different intracellular Mg²⁺ concentrations ([Mg²⁺]i). In control group, which was treated with 0.9 mmol/L Mg²⁺, the relative activity of calcium channel was (176.5 ± 34.1)% (n = 7). When [Mg²⁺]i was increased from 0.9 to 8.1 mmol/L (high Mg²⁺ group), the relative activities of calcium channel decreased to (64.8 ± 18.1)% (n = 6, P < 0.05). Moreover, under 8.1 mmol/L Mg²⁺, the mean open time of calcium channel was shortened to about 25% of that under control condition (P < 0.05), but the mean close time of calcium channel was not altered. These results suggest that high intracellular Mg²⁺ may inhibit the activities of L-type calcium channel, which is mainly due to the shortening of the mean open time of single L-type calcium channel.


Subject(s)
Animals , Calcium Channels, L-Type , Physiology , Guinea Pigs , Magnesium , Physiology , Myocytes, Cardiac , Physiology , Patch-Clamp Techniques
2.
Acta Pharmaceutica Sinica ; (12): 488-491, 2007.
Article in English | WPRIM | ID: wpr-268612

ABSTRACT

Polysaccharide sulfate (PSS) is a new type of antiatherosclerotic medicine for its effects of anticoagulation, anti-thrombosis and modulation of dyslipidemia. However, it is still uncertain whether PSS could modulate the diabetic dyslipidemia or not. Here, the rat model of diabetic dyslipidemia was developed and the effects of PSS on glucose and lipid levels were investigated in this animal model. Wistar rats were iv injected with streptozotocin 20 mg x kg(-1) after feeding with high fat diet for one and a half month. Then, rats received orally PSS (30, 90, and 180 mg x kg(-1)) for 1 month. After oral treatment with PSS (90 and 180 mg x kg(-1)) for 1 month, the levels of triglyceride (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) were significantly reduced and the level of high density lipoprotein-cholesterol (HDL-C) increased, compared with diabetic control rats. Moreover, PSS (30, 90, and 180 mg x kg(-1)) had a tendency to reduce glucose and insulin levels, and significantly increased insulin sensitivity index. Our results suggest that PSS could improve insulin sensitivity and relieve dyslipidemia in diabetic dyslipidemic rats.


Subject(s)
Animals , Male , Rats , Administration, Oral , Blood Glucose , Metabolism , Cholesterol, HDL , Blood , Cholesterol, LDL , Blood , Diabetes Mellitus, Experimental , Blood , Dyslipidemias , Blood , Hypolipidemic Agents , Pharmacology , Insulin , Blood , Insulin Resistance , Polysaccharides , Pharmacology , Random Allocation , Rats, Wistar , Streptozocin , Sulfates , Pharmacology , Triglycerides , Blood
SELECTION OF CITATIONS
SEARCH DETAIL